Diphenyl difluoroketone: a potent chemotherapy candidate for human hepatocellular carcinoma.
Diphenyl difluoroketone: a potent chemotherapy candidate for human hepatocellular carcinoma.
复制标题
二苯基二氟酮:人类肝细胞癌的有效化疗候选物。
DOI:
10.1371/journal.pone.0023908
复制
发表时间:
2011
期刊:
影响因子:
3.7
通讯作者:
Liu L
中科院分区:
文献类型:
--
作者:
Liang Y;Yin D;Hou L;Zheng T;Wang J;Meng X;Lu Z;Song X;Pan S;Jiang H;Liu L
Diphenyl difluoroketone (EF24), a molecule having structural similarity to curcumin, was recently reported to inhibit proliferation of various cancer cells significantly. Here we try to determine the effect and mechanism of EF24 on hepatocellular carcinoma. 2 µM EF24 was found to inhibit the proliferation of PLC/PRF/5, Hep3B, HepG2, SK-HEP-1 and Huh 7 cell lines. However, even 8 µM EF24 treatment did not affect the proliferation of normal liver LO2 cells. Accordingly, 20 mg/kg/d EF24 inhibited the growth of the tumor xenografts conspicuously while causing no apparent change in liver, spleen or body weight. In addition, significant apoptosis and G2/M phase cell cycle arrest were found using flow cytometry. Besides, caspases and PARP activation and features typical of apoptosis including fragmented nuclei with condensed chromatin were also observed. Furthermore, the mechanism was targeted at the reduction of nuclear factor kappa b (NF-κB) pathway and the NF-κB–regulated gene products Bcl-2, COX-2, Cyclin B1. Our study has offered a strategy that EF24 being a therapeutic agent for hepatocellular carcinoma.
登录
查看更多内容
影响因子:
2.3
作者:
Adams, BK;Cai, JY;Shoji, M
通讯作者:
Shoji, M
影响因子:
3.5
作者:
Adams, BK;Ferstl, EM;Shoji, M
通讯作者:
Shoji, M
影响因子:
3.6
作者:
Kasinski, Andrea L.;Du, Yuhong;Fu, Haian
通讯作者:
Fu, Haian
影响因子:
4.4
作者:
Khoshnan, A;Tindell, C;Nel, AE
通讯作者:
Nel, AE
影响因子:
3.6
作者:
Choi, Hyunsung;Chun, Yang-Sook;Park, Jong-Wan
通讯作者:
Park, Jong-Wan